Free Trial

Comera Life Sciences (CMRA) Competitors

Comera Life Sciences logo
$0.0002 0.00 (0.00%)
As of 07/23/2025

CMRA vs. SCPS, VAXX, AMPE, NAVB, EVLO, GNCAQ, GNCA, ARDS, STAB, and EFTR

Should you be buying Comera Life Sciences stock or one of its competitors? The main competitors of Comera Life Sciences include Scopus BioPharma (SCPS), Vaxxinity (VAXX), Ampio Pharmaceuticals (AMPE), Navidea Biopharmaceuticals (NAVB), Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), and eFFECTOR Therapeutics (EFTR). These companies are all part of the "pharmaceutical products" industry.

Comera Life Sciences vs. Its Competitors

Scopus BioPharma (NASDAQ:SCPS) and Comera Life Sciences (NASDAQ:CMRA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, media sentiment, institutional ownership and analyst recommendations.

Scopus BioPharma has higher earnings, but lower revenue than Comera Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Scopus BioPharmaN/AN/A-$11.61MN/AN/A
Comera Life Sciences$1.00M0.01-$18MN/AN/A

In the previous week, Scopus BioPharma's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company Overall Sentiment
Scopus BioPharma Neutral
Comera Life Sciences Neutral

Scopus BioPharma has a beta of -0.19, meaning that its stock price is 119% less volatile than the S&P 500. Comparatively, Comera Life Sciences has a beta of 1.27, meaning that its stock price is 27% more volatile than the S&P 500.

Company Net Margins Return on Equity Return on Assets
Scopus BioPharmaN/A N/A N/A
Comera Life Sciences N/A N/A N/A

Summary

Comera Life Sciences beats Scopus BioPharma on 2 of the 3 factors compared between the two stocks.

Get Comera Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CMRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

CMRA vs. The Competition

MetricComera Life SciencesPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$6K$772.21M$5.71B$9.51B
Dividend YieldN/A4.84%4.60%3.99%
P/E RatioN/A1.3928.0720.02
Price / Sales0.0126.96459.47103.02
Price / CashN/A19.5636.5558.97
Price / BookN/A6.798.615.88
Net Income-$18M-$4.32M$3.24B$258.50M
7 Day PerformanceN/A1.31%3.83%2.03%
1 Month PerformanceN/A3.68%10.40%12.52%
1 Year PerformanceN/A8.08%34.13%19.07%

Comera Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMRA
Comera Life Sciences
N/A$0.00
flat
N/AN/A$6K$1.00M0.002
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13KN/A0.009
VAXX
Vaxxinity
N/A$0.00
flat
N/A-56.0%$13KN/A0.0090Gap Up
AMPE
Ampio Pharmaceuticals
N/A$0.01
+9,900.0%
N/A+145.5%$11KN/A0.0020Gap Down
High Trading Volume
NAVB
Navidea Biopharmaceuticals
N/A$0.00
-50.0%
N/A-50.0%$10K$8.13K0.0010
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$9KN/A0.00120News Coverage
Options Volume
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
ARDS
Aridis Pharmaceuticals
N/A$0.00
+∞
N/AN/A$5KN/A0.0030Gap Up
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020Negative News
EFTR
eFFECTOR Therapeutics
0.073 of 5 stars
$0.00
flat
N/A-99.6%$1KN/A0.0010Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:CMRA) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners